Watch Ticker

MoonLake Immunotherapeutics Class A Ordinary Shares

Go to MoonLake Immunotherapeutics Class A Ordinary Shares Website

$53.43

0.11 (0.21%)

Live

Previous Close

$53.32

Day Range

$52.32 - $53.75

Previous Day Range

$52.1 - $53.78

Market Cap

$3.4 billion USD

Day Vol.

219545

Previous Day Vol.

482312

Currency

USD

Primary Exchange

Nasdaq

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibit...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery

The FDA has approved Merck's Keytruda for use as a neoadjuvant and adjuvant treatment for certain patients with head and neck cancer, making it the first immunotherapy approved for use around surgery for this indication.

Related tickers: MRK, MLTX.

Read Full Article

Delveinsight - Psoriasis Market Outlook in the 7MM Through 2034: In-Depth Analysis by Psoriasis Type | DelveInsight

The psoriasis pipeline has several drugs in mid- and late-stage development, including Imsidolimab, TAK-279, and Sonelokimab, which are expected to positively impact the market. The treatment landscape is expanding with new therapies from various companies.

Related tickers: ANAB, MLTX, EVLO.

Read Full Article

Trending Tickers

Please sign in to view